Josephine Issakov

Medicine & Life Sciences

1. Ewing's Sarcoma 100%
2. Sarcoma 90%
3. Neoplasms 56%
4. Extremities 52%
5. Recurrence 30%
6. Bone and Bones 30%
7. Osteosarcoma 27%
8. Drug Therapy 27%
9. Radiotherapy 18%
10. Aggressive Fibromatosis 17%
11. Cryosurgery 16%
12. Alveolar Rhabdomyosarcoma 16%
13. Survival 15%
14. Chondrosarcoma 15%
15. Doxorubicin 14%
16. Clinical Protocols 14%
17. Liposarcoma 14%
18. Necrosis 13%
19. Melphalan 13%
20. Progression-Free Survival 12%
21. Induction Chemotherapy 12%
22. Amputation 12%
23. Child 12%
24. gemcitabine 11%
25. Osteomyelitis 11%
26. Tumor Necrosis Factor-alpha 11%
27. Therapeutics 10%
28. ErbB Receptors 10%
29. erbB-2 Genes 9%
30. Osteofibrous Dysplasia 9%
31. Disease-Free Survival 9%
32. Ifosfamide 9%
33. Neoplasm Metastasis 9%
34. Perfusion 9%
35. ATP Binding Cassette Transporter, Subfamily B, Member 1 9%
36. Myxoid Liposarcoma 8%
37. Reduced Folate Carrier Protein 8%
38. Malignant Fibrous Histiocytoma 8%
39. Coccyx 8%
40. Neurosarcoidosis 8%
41. Ossifying Fibroma 8%
42. Neurofibrosarcoma 8%
43. Bone Marrow 8%
44. Growth 8%
45. heparanase 7%
46. Synovial Sarcoma 7%
47. Oncogene Proteins 7%
48. Fibrosarcoma 7%
49. Fasciitis 7%
50. Embryonal Rhabdomyosarcoma 7%